Alt image -https://content.stockstotrade.com/wp-content/uploads/2026/11/fabrinet-stock-jumps-as-record-quarter-fuels-bullish-guidance.jpg

Fabrinet Stock Jumps As Record Quarter Fuels Bullish Guidance

TIM BOHEN•UPDATED NOV. 3, 2026, 2:05 PM ET
Reviewed by Ben Sturgilland Fact-checked by Ellis Hobbs

Fabrinet stocks have been trading up by 17.96 percent after upbeat earnings and AI-related demand fueled investor optimism.

Key Takeaways

  • Record Q1 FY27 from Fabrinet showed revenue up 51% year-over-year and non-GAAP EPS up about 49%, both topping guidance on broad-based demand and new product ramps.
  • For fiscal Q1, FN delivered adjusted EPS of $4.34 versus $4.19 consensus and revenue of $1.474B versus $1.4B, signaling strong execution on both revenue and profits.
  • Management guided Q2 sharply higher, targeting EPS of $4.77–$4.92 and revenue of $1.6B–$1.65B against Street estimates of $4.43 and $1.48B.
  • FN’s board boosted its share repurchase plan by $103M to $637.3M, underscoring confidence in cash generation and valuation.
  • Several firms cut price targets on Fabrinet but kept Positive or Neutral views, still calling out strong optical and AI-driven demand into 2027 despite sector-wide macro worries.

Candlestick Chart

Get Free Alerts

Live Update At 14:04:40 EST: On Tuesday, November 03, 2026 Fabrinet stock [NYSE: FN] is trending up by 17.96%! Discover the key drivers behind this movement as well as our expert analysis in the detailed breakdown below.

Quick Financial Overview

FN’s chart looks like a textbook earnings squeeze. After closing at $314.70 on 2026/11/02, Fabrinet exploded to a $329.99 open and finished the next session at $370.62. That’s a massive multi-day rebound from the recent pullback off the $500+ zone seen earlier in October, when FN printed a high near $515 before sliding into the low-$300s.

Intraday, Fabrinet showed steady accumulation. The stock jumped from the open, shook out around the mid-$350s, then ground higher into the close near the day’s top. For short-term traders, that kind of trend day signals real demand, not just a one-candle headline spike.

More Breaking News

Under the hood, FN is not a story stock with no profits. Fabrinet runs EBIT margins around 12% and posts double-digit returns on equity north of 20%. Revenue over the last few years has grown around 20% annually, backed by an asset-light, high-turnover model. On valuation, FN trades at a rich P/E near 37 and a price-to-sales around 3.75, so this is a momentum-and-growth name. For active traders, that means strong trends when the story is hot, but sharp pullbacks when sentiment flips.

Why Traders Are Watching Fabrinet Now

FN is front and center on traders’ screens because the fundamentals and the tape are finally moving in the same direction again. Fabrinet delivered a record Q1 FY27: revenue jumped 51% year-over-year and non-GAAP EPS climbed about 49%, both above its own guidance. Management didn’t blame “one big customer” either. They pointed to broad-based demand and new product ramps across key programs, which tells traders this isn’t a single-contract sugar high.

On top of the beat, FN raised the stakes with aggressive Q2 guidance. Fabrinet now expects adjusted EPS between $4.77 and $4.92, compared with Wall Street at $4.43. Revenue is pegged at $1.6B–$1.65B versus the $1.48B consensus. When a company already growing this fast leans into higher numbers, momentum traders pay attention. The market did exactly that: FN ripped higher in after-hours trading as these numbers hit, then followed through during regular hours.

Fabrinet’s board also expanded its share repurchase authorization by $103M, bringing total capacity to $637.3M. For traders, that matters. A buyback of that size can act like a floor when the stock dips, especially with FN’s balance sheet sitting on strong cash and essentially no net debt.

The backdrop is not all sunshine. Susquehanna cut its price target on FN from $850 to $600, JPMorgan dropped from $695 to $465, and B. Riley went down to $385. All kept Positive or Neutral ratings, and they all still highlighted durable optical and AI-related demand into 2027. The message: the business is humming, but the sector is wrestling with tighter credit and capex worries from big cloud customers. That tension between blazing fundamentals and cautious targets is exactly what makes Fabrinet a lively trading vehicle right now.

Conclusion

For active traders, FN is a classic momentum-growth setup with real numbers behind the story. Fabrinet just posted a powerful trifecta: a Q1 beat on both revenue and EPS, year-over-year growth above 50% on the top line, and Q2 guidance that blows past Street expectations. The expanded $637.3M buyback adds another layer of support, signaling that management believes the current Fabrinet share price undervalues the long-term cash engine.

But this is not a simple straight-line story. The stock ran from the $300s into the $500s earlier in the month, then sold off hard before this latest surge. Analyst price-target cuts from Susquehanna, JPMorgan, and B. Riley remind traders that valuation is stretched and macro risks—especially cloud and AI capex—are real. FN’s P/E near 37 and high price-to-book ratio say you’re paying up for growth and execution.

That’s why discipline matters. Fabrinet rewards traders who respect both the trend and the risk. As Tim Sykes loves to repeat, “Cut losses quickly; don’t fall in love with any stock.” As Tim Bohen, lead trainer with StocksToTrade says, “The best trades are the ones you can make without emotion. Plan it, then execute it as if it’s routine.” FN’s strength, liquidity, and news flow make it a prime educational case study: chase confirmed momentum, trade the catalysts, and always have an exit plan before you ever hit the buy button.

This is stock news, not investment advice. StocksToTrade News delivers real-time stock market updates tailored to highlight the key catalysts driving short-term price movements. Our coverage is designed for active traders and investors who thrive in fast-moving markets, with a focus on volatile sectors like penny stocks, AI stocks, Robinhood stocks and other momentum plays. From earnings reports and FDA approvals to mergers, new contracts, and unusual trading volume, we break down the events that can spark significant price action.

Looking to level up your trading game? Explore StocksToTrade, the ultimate platform for traders. With powerful tools designed for swing and day trading, integrated news scanning, and even social media monitoring, StocksToTrade keeps you one step ahead.

Check out our quick startup guide for new traders!

Ready to build your watchlists? Check out these curated lists:

Once your watchlist is set, take the next step and trade with confidence using StocksToTrade’s robust platform. Don’t miss out — grab your 14-day trial for just $7 and experience the edge you need to thrive in today’s fast-paced markets.


The Game is Rigged

But Our AI-driven analysis Has Leveled the Playing Field

Sign up for access to institutional grade tools and insights – and join 10,000+ traders